The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.05 (-3.70%)
Spread: 0.20 (16.667%)
Open: 1.35
High: 1.35
Low: 1.30
Prev. Close: 1.35
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Project and Grant Funding

15 Nov 2010 15:23

RNS Number : 2044W
Physiomics PLC
15 November 2010
 



Physiomics plc

("Physiomics" or "the Company")

Physiomics to collaborate with Green Biologics Limited and North Energy Associates Limited in the Carbon Trust funded project:

Advanced Fermentation Process for Butanol

 

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that the Company together with Green Biologics Limited (GBL) and North Energy Associates Limited has been awarded a total grant for £268,000 from the Carbon Trust for a project to demonstrate an Advanced Fermentation Process for Butanol.

 

The aim is to improve the microbial fermentation process for producing renewable butanol (a "next generation" biofuel) using solventogenic Clostridia. The project will focus on improvements in butanol productivity using a novel bioreactor design together with improved microbes and cheaper more sustainable feedstock found in the UK. Example feedstock includes sugar beet pulp, distillers dried grains & solubles (DDGS) and municipal solid waste.

 

The advanced butanol fermentation process should reduce production costs below $500/ tonne making it cost competitive with first generation biofuels. In addition, the use of renewable and sustainable feedstock supports significant savings in net greenhouse gas (GHG) emissions in the UK, which could total 1,230,000 t eq. CO2/ annum by 2020.

 

GBL will lead, coordinate and manage the project. GBL will deliver improved biocatalysts and demonstrate a novel fermentation process at laboratory and pilot scale. Physiomics will model microbial population and provide input into how best to optimise the fermentation process. North Energy will complete life cycle assessment (LCA) of the process on model biomass feedstock applicable to the UK.

 

The project will occur in two stages: the first stage of the project is due to be completed by 31 March 2011 and the second stage is due to complete 18 months later on 30 September 2012. Full grant funding (for the second stage) and continuation of the project beyond stage 1 is conditional on achieving certain technical milestones during stage 1 for which Physiomics will receive approximately £31,000.

 

The grant is from the Carbon Trust's Entrepreneurs Fast Track scheme which provides a customised package of research and development funding, expert advice and enhanced networking opportunities to the leading UK clean tech ventures with the highest growth potential.

Physiomics shall grant GBL an exclusive licence to use the intellectual property they develop during the project for butanol production. In return, GBL shall pay Physiomics a royalty upon commercialisation that is commensurate with their contribution to reducing the cost of butanol production.

 

Dr Christophe Chassagnole, COO of Physiomics, said

 

"We are delighted that our project has been selected by an innovation-supporting body such as the Carbon Trust. This is also a landmark in our diversification strategy as it would be the first non-pharmaceutical application of our technology. We look forward to working with the partners of the consortium"

 

 

Dr Edward Green, CTO of Green Biologics Limited, said

 

"The funding enables us to accelerate our work on non-edible feedstock prevalent in the UK. This not only helps drive down the cost of bio-butanol production making it cost competitive for the biofuel market but also improves the sustainability of the process and reduces GHG emissions compared with first generation biofuels. This technology breakthrough offers a tremendous opportunity to commercialise the butanol fermentation in the UK.

 

Dr Nigel Mortimer, MD of North Energy Associates Limited, said

 

"North Energy is very pleased to be able to contribute our established expertise in carbon accounting to this important development which offers significant improvements in greenhouse gas emissions reductions. The development and commercialisation of new processing technologies for the production of sustainable biofuels from diverse and abundant feedstock is essential for the transformation of our transport systems to practical low-carbon alternatives."

 

 

 

Enquiries:

 

Physiomics plc

Dr Christophe Chassagnole, COO

+44 (0)1865 784980

 

WH Ireland Limited

Katy Mitchell

+44 (0) 161 832 2174

 

 

Information on Physiomics plc

Physiomics (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market, estimates show that an overall ten per cent improvement in success rates could reduce the cost of one drug's development by as much as $242 million, from the current estimate of around $800 million.

Physiomics develops computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to clinical development. Physiomics has created detailed mathematical models incorporating the most important molecular events taking place during the human cell cycle and apoptosis processes. The company's SystemCell® technology enables the simulation of populations of "virtual cells". The models are used to optimise compound design, as well as to design drug schedules and combination therapies.

 

Physiomics, based in Oxford, UK, was founded in 2001, and floated on AIM in 2004. For further information, please visit www.physiomics-plc.com

 

 

Information on Green Biologics Limited

Green Biologics Ltd (GBL) is an industrial biotechnology company that provides innovative bio process solutions for butanol in a global market. The technology produces environmentally friendly and sustainable biofuels with significant potential for GHG reduction by delivering technical improvements in the fermentation process accommodating a wide range of low cost and sustainable agricultural by-products and waste streams resulting in a faster, cleaner and more efficient process.

 

For further information, please visit www.greenbiologics.com

 

Information on North Energy Associates Limited

North Energy Associates Ltd. is a long-established renewable energy and sustainability consultancy. From offices in Northumberland and Yorkshire, the team has delivered renewable energy and sustainability solutions to business, industry and commerce in the UK and beyond since 1992. One particular area of specialisation has been life cycle assessment, in general, and carbon accounting, in particular. Our clients include many biofuel developers and producers as well as government department and agencies.

For further information, please visit www.northenergy.co.uk

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFEFIIFSSEEF
Date   Source Headline
3rd May 20247:00 amRNSTrading Update
21st Mar 20247:00 amRNSIMC Presentation on Company Website
18th Mar 20247:00 amRNSContract Award
7th Mar 20247:00 amRNSInterim Results
1st Mar 20243:00 pmRNSNotice of Results and Investor Presentation
19th Feb 20247:00 amRNSContract Award
6th Feb 20247:00 amRNSOptions Award
5th Feb 20247:00 amRNSContract Award
2nd Feb 20247:00 amRNSIMC Presentation on Company Website
23rd Jan 20247:00 amRNSIMC Presentation on Board Changes
22nd Jan 20247:00 amRNSBoard Changes
21st Nov 20233:30 pmRNSResult of AGM
10th Nov 20233:14 pmRNSBusiness Update Presentation
10th Nov 20237:00 amRNSInnovate UK grant award
18th Oct 20237:00 amRNSNotice of AGM
4th Oct 20237:00 amRNSChange of Registered Office
3rd Oct 20237:00 amRNSSenior Management Announcement
28th Sep 20237:00 amRNSAnnual Financial Report
4th Sep 20237:00 amRNSSenior Management Update
31st Aug 20231:00 pmRNSContract Award
31st Aug 20237:00 amRNSContract Award
8th Aug 20237:45 amRNSContract Award
4th Aug 20237:00 amRNSContract Award
25th Jul 20237:00 amRNSDirector Dealing
18th Jul 20237:00 amRNSDirector Dealing
29th Jun 20237:00 amRNSCompletion of Placing, Subscription & Retail Offer
27th Jun 20237:01 amRNSWRAP Retail Offer for up to £150,000
27th Jun 20237:00 amRNSCompletion of Equity Fundraise
31st May 20237:00 amRNSCollaboration with The University of Sheffield
23rd May 20237:00 amRNSTrading Update
9th May 20237:00 amRNSPublication of article in Frontiers in Oncology
26th Apr 20237:00 amRNSCollaborative Services Agreement
14th Apr 20237:00 amRNSPhysiomics to present at AACR Annual Meeting
4th Apr 20237:00 amRNSTrading and Company Update
28th Mar 20237:00 amRNSAnnouncement of Collaboration
10th Mar 20237:00 amRNSContract announcement
7th Mar 20237:00 amRNSInterim Results
13th Jan 20237:00 amRNSChange in role of board Director
11th Jan 20237:00 amRNSContract announcement
9th Jan 20237:00 amRNSCompletion of PARTNER study
22nd Nov 20224:00 pmRNSResult of AGM
10th Nov 20228:50 amRNSContract award
9th Nov 20227:00 amRNSPYC to present and exhibit at SITC Annual Meeting
27th Oct 20227:00 amRNSAnnual Report and AGM Notice
14th Oct 20227:00 amRNSConference Attendance
12th Oct 20227:00 amRNSContract Award
4th Oct 20227:00 amRNSContract Award
29th Sep 20227:00 amRNSInterim Results
9th Sep 20227:00 amRNSNotice of Results
1st Sep 20227:00 amRNSAppointment of Independent Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.